Financial Select Sector SPDR Fund vs 22nd Century Group Inc — how do they compare? Financial Select Sector SPDR Fund trades at $54.73 (market cap $50.06B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Financial Select Sector SPDR Fund is far larger — about 80525× 22nd Century Group Inc's market cap, and Financial Select Sector SPDR Fund is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Financial Select Sector SPDR Fund for 104 Days and 22nd Century Group Inc for 32 Days on average.
| XLF | XXII | |
|---|---|---|
Market Cap | $50.06B | $621.67K |
Volume | 47,464,120 | 45,625 |
52-Week High | $58.55 | $483.00 |
52-Week Low | $47.80 | $0.80 |
Typical Hold Time | 104 Days | 32 Days |
Sector | — | Consumer Staples |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
XLF trades at $54.23, up 0.89% on the day, while technical indicators show a bearish bias with moving averages signaling caution. The ETF faces sector headwinds as financial stocks lag the S&P 500 by the widest margin since 1990 despite rising bank profits. Recent Fed stress test changes and interest rate hikes create both opportunities and challenges for financial sector performance.
Financial sector exposure through XLF offers potential upside from rising interest rates, though regulatory uncertainty and market underperformance present near-term risks. The ETF's focus on large-cap financial firms provides stability, but sector rotation trends and political volatility could impact medium-term returns.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →